The Chemistry Core will synthesize novel molecular probes for biological studies on cocaine addiction that will be available for the various projects and pilot projects within the Center. These molecular probes will enable the Center to explore central questions regarding cocaine addiction. """"""""Chemical knockouts"""""""" blocking the monoamine transporters will be generated and used to study cocaine sensitization. Selective serotonin transporter (SERT) inhibitors will be used to study the role of the SERT inhibition on cocaine addiction. New neuroimaging agents will be generated to study dopamine transporter (DAT) and SERT neurochemical changes in the brain. Differentially functionalized radiolabeled irreversible ligands will be prepared to study the binding sites of DAT inhibitors. The Chemistry Core will interact with virtually all the other projects in the Center. Interaction with subproject 0001 (Childers) will be very extensive because a major component of subproject 0001 will be the use ol radiolabeled irreversible inhibitors to map the DAT. Promising irreversible inhibitors will also be evaluated behaviorally in subproject 0005 (Smith/Martin). Subproject 0008 (Vrana) will be exploring the effects of long acting tropanes on specific gene expression, with emphasis on connexins. One component of subproject 0011 (Roberts) will be the exploration of how the chronisity of cocaine administration impacts regional effects and connexin proteins in the brain. Long acting tropanes will be useful molecular tools for this project. Precursors to PEr radioligands will be prepared for the PET Imaging Core and these will be used in subProject 0012 (Porrino) and 0009 (Nader). The development of new radioligands is proposed in collaborative studies involving the Pilot Projects. A major component of Project 7 is to investigate the ability of compounds from the Chemistry Core with selectivity for SERT to selectively decrease cocaine self-administration in rhesus monkeys.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA006634-17
Application #
7614193
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
17
Fiscal Year
2008
Total Cost
$143,071
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Siciliano, Cody A; Saha, Kaustuv; Calipari, Erin S et al. (2018) Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation. J Neurosci 38:484-497
Ilyasov, Alexander A; Milligan, Carolanne E; Pharr, Emily P et al. (2018) The Endocannabinoid System and Oligodendrocytes in Health and Disease. Front Neurosci 12:733
Ding, Huiping; Kiguchi, Norikazu; Yasuda, Dennis et al. (2018) A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates. Sci Transl Med 10:
Chen, R; McIntosh, S; Hemby, S E et al. (2018) High and low doses of cocaine intake are differentially regulated by dopamine D2 receptors in the ventral tegmental area and the nucleus accumbens. Neurosci Lett 671:133-139
John, William S; Martin, Thomas J; Solingapuram Sai, Kiran Kumar et al. (2018) Chronic ?9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability. J Pharmacol Exp Ther 364:300-310
Raab-Graham, Kimberly F; Niere, Farr (2017) mTOR referees memory and disease through mRNA repression and competition. FEBS Lett 591:1540-1554
Howlett, Allyn C; Abood, Mary E (2017) CB1 and CB2 Receptor Pharmacology. Adv Pharmacol 80:169-206
Deadwyler, Sam A; Hampson, Robert E; Song, Dong et al. (2017) A cognitive prosthesis for memory facilitation by closed-loop functional ensemble stimulation of hippocampal neurons in primate brain. Exp Neurol 287:452-460
John, William S; Nader, Michael A (2017) Effects of ethanol on cocaine self-administration in monkeys responding under a second-order schedule of reinforcement. Drug Alcohol Depend 170:112-119
Blume, Lawrence C; Patten, Theresa; Eldeeb, Khalil et al. (2017) Cannabinoid Receptor Interacting Protein 1a Competition with ?-Arrestin for CB1 Receptor Binding Sites. Mol Pharmacol 91:75-86

Showing the most recent 10 out of 310 publications